BHS GUIDELINES FOR THE MANAGEMENT OF SMALL LYMPHOCYTIC LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKAEMIA, ANNO 2024

Janssens, A; André, Marc

BHS GUIDELINES FOR THE MANAGEMENT OF SMALL LYMPHOCYTIC LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKAEMIA, ANNO 2024

Janssens, A

;

André, Marc

(2023) Belgian Journal of Hematology — Vol. 14, n° 7, p. 278-303 (2023)

Files

JanssensABelgJHematol2023.pdf

Open Access
Adobe PDF
14.18 MB

Download

Details

Authors

Janssens, A
Author
André, MarcUCLouvain
Collaborator

Abstract

The Belgian Haematological Society (BHS) Lymphoproliferative disease (LPD) committee updated the existing recommendations on diagnosis, prognostic scores, best strategies for front-line and subsequent-line treatment of small lymphocytic lymphoma (SLL)/chronic lymphocytic leukaemia (CLL), according to robust new data.

Affiliations

UCLouvainSSS/IREC/MONT - Pôle Mont Godinne
UCLouvain(MGD) Service d'hématologie

Citations

APA
Chicago
FWB

Janssens, A. (2023). BHS GUIDELINES FOR THE MANAGEMENT OF SMALL LYMPHOCYTIC LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKAEMIA, ANNO 2024. Belgian Journal of Hematology, 14(7), 278-303. https://hdl.handle.net/2078.5/27758 (Original work published 2023)